NPPA and cardiac hypertrophy: Previous studies have shown that patients with cardiovascular disease not only exhibit ventricular systolic dysfunction but also are often associated with the main features of pathological myocardial fibrosis, cardiac hypertrophy, and re-expression of atrial natriuretic peptide and B-type natriuretic peptide [13,44,45].